Efficacy of pegfilgrastim (PF) for neutrophil recovery after autologous stem cell transplant (ASCT)  by Frame, D. et al.
407
EFFICACY OF PEGFILGRASTIM (PF) FOR NEUTROPHIL RECOVERY AF-
TER AUTOLOGOUS STEM CELL TRANSPLANT (ASCT)
Frame, D.1, Drajer, D.1, Myint, H.2, Kang, E.1, Vujovic, M.1,
Fung, H.1 1. Rush University Medical Center, Chicago, IL; 2. Univer-
sity of Colorado Health Science Center, Aurora, CO.
Background: Daily ﬁlgrastim or sargramostim are commonly used
to decrease the time to neutrophil engraftment (NE) after ASCT.
Since a single 6 mg dose of PF has been shown to be as effective as
daily ﬁlgrastim (F) in decreasing the duration of neutropenia after
standard chemotherapy, this study explored the effectiveness of a
single dose of PF after high dose chemotherapy and ASCT in adults
withmultiple myeloma (MM) or lymphoma (L).Methods:Originally
5 patients (pts) were enrolled in a pilot study to determine the efﬁcacy,
safety, and kinetics of PF given on day 5 after stem cell infusion.
After efﬁcacy and safety was demonstrated in these patients the stan-
dard protocol was changed to use PF on day3 after ASCT. In total
16 pts have received PF after conditioning with melphalan (200
mg/m2) for MM (n 6) or Rituxan BEAM (n 6) or Rituxan-TBI-
Cyclophosphamide (n  4). A retrospective comparison was also
made to 60 pts who had received sargramostim(SM) for NE after
ASCT in the previous 12months.Results:All pts treated with PF had
engraftment of neutrophils and platelets. The median time to NE to
ANC 	 500 was 8.5 days (range 7–11) and to ANC 	 1000 was 9.3
days. Average CD34 cells infused were 4.9  106/kg. The median
time to platelet engraftment was 11.8 days (range 3–21). There were
no adverse events associated with PF. The retrospective analysis of 60
patients treated with SM resulted in median time to NE of 11 days
(range 9–14) with a median of 8 days of SM administration (range
6–11). Conclusions: A single dose of 6 mg PF administered SQ on
days 3 to 5 after ASCT is safe and results in rapid neutrophil
engraftment that appears to be at least comparable to daily SM. All
patients preferred the single injection. The platelet engraftment time
also appeared to be rapid. PF is a reasonable option in pts receiving
ASCT.
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DESCRIPTIVE ANALYSIS ON THE ROLE AND OUTCOMES OF PSYCHO-
LOGICAL EVALUATION AND INTERVENTION IN PATIENTS UNDERGO-
ING STEM CELL TRANSPLANT
Hoerster, C.M.1, Bachier, C.1, LeMaistre, C.F.1, Shaughnessy, P.1 1Texas
Transplant Institute Methodist Healthcare System, San Antonio, TX.
Background: Mental health problems often go undiagnosed
and can complicate the management of patients (pts) after stem
cell transplantation (SCT). In 2004, we established a clinical
service with deﬁned providers who focused on the mental health
needs of the SCT patients. Prior to this time pts were referred
to available community providers as needs were identiﬁed. This
descriptive retrospective study evaluates the practical utilization
of psychological and psychiatric services in the ﬁrst year of this
program and the role of mental health providers in a large SCT
program. Results: 172 pts underwent SCT in the 1-year period
designated for data analysis. Of these pts, 55 (32%) were re-
ferred for psychological services that included evaluation and
therapeutic intervention by a clinic psychologist. Of the pts
referred for psychological services, the average age was 47 years,
with 26 males and 28 females. Twenty-four were Caucasian, 15
were Hispanic, and 1 was African American. Pts were referred
for evaluation by SCT physicians, primarily for mood symp-
toms. These symptoms indicated depression, anxiety, or poor
general coping. Other reasons for referral included smoking
cessation, prior history of psychiatric illness, family issues, ste-
roid-related mania, cognitive changes, panic disorder, “denial”
of illness, and family dysfunction. DSM-IVR diagnoses included
major depressive disorder (14), mood disorder related to diag-
nosis and treatment (13), dual diagnosis, either with nicotine
dependence, drug or alcohol dependence with concurrent mood
disorder (12), and bipolar type disorder unrelated to medica-
tions (7). Diagnosis was deferred for 6 patients. Three patients
received adjustment related diagnoses. Twenty-four (40%) pts
evaluated by the psychologist were referred for further evalua-
tion for psychiatric medications by a psychiatrist or psychiatric
clinical nurse specialist. Thirty-one pts were placed on medica-
tions. Pts were followed throughout their pre- and post-trans-
plant course for an average of 6.4 sessions. Referrals for services
increased throughout the ﬁrst year of the program. Conclu-
sions: Results of this retrospective study reﬂect the utilization
of psychological services provided in the ﬁrst year of services.
The number of moderate to severe psychiatric diagnoses de-
notes the importance of the availability of psychological ser-
vices. The study establishes a need for continued prospective
research in this population with a focus on detection and devel-
opment of useful interventions.
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BACTERIAL CONTAMINATION OF PLATELET CONCENTRATES: INACTI-
VATE OR SCREEN?
Grabmer, C.1, Lass-Floerl, C.2, Allersdorfer, D.1, Rheinschmidt, M.3,
Lin, L.3, Schoenitzer, D.1, Nussbaumer, W.1 1. Department of Trans-
fusion Medicine, University Hospital Innsbruck, Innsbruck, Austria; 2.
Institute for Hygiene and Social Medicine, University of Innsbruck,
Innsbruck, Austria; 3. Cerus Corporation, Concord, CA.
Background: Platelets (PLTs) are stored under conditions
that favor bacterial growth and therefore bacterial contamina-
tion is considered a serious problem in transfusion. Most fre-
quent indications for repeated PLT transfusions are neutro-
penic patients during ablative chemotherapy and the incidence
of non-fatal transfusion transmitted sepsis in these patients may
be under diagnosed. This study compares efﬁcacy of bacterial
screening (BacT/Alert) versus pathogen inactivation (INTER-
CEPT) of PLT concentrates before transfusion. Material and
Methods: 7 species of bacteria (Staphylococcus aureus, Staphylo-
coccus epidermidis, Streptococcus agalactiae, Klebsiella pneumoniae,
Escherichia coli, Propionibacterium acnes, and Clostridium perfrin-
gens) were inoculated at three different concentration levels
(1–10, 10–100, 100–1000 CFU/PLT unit) into double-dose
PLTs. After inoculation the units were divided and one of the
paired units was treated with INTERCEPT. Samples were
taken from both units on day 1, 2, and 5 of storage and inocu-
lated into culture bottles (BacT/Alert) to detect bacteria. PLTs
were considered negative if no bacterial growth was detected
after 120 hours of culture. Results: For untreated PLTs seeded
with 100–1000 CFU/unit of bacteria cultures were positive in
86% of units before day 5. Inoculation with 1–10 CFU/unit or
10–100 CFU/unit resulted in negative cultures in 71% and 43%
of units by day 5, respectively. All PLTs contaminated with
bacteria and treated with INTERCEPT remained negative
through day 5 regardless of species, level of contamination, and
sampling time. Conclusions: Bacterial detection using cultures
may fail to detect low levels of bacteria typically associated with
platelet contamination at time of collection and processing.
Failure to detect bacteria will result in the release of contami-
nated platelet products with “test negative-to-date” status. In
contrast, inactivation of bacteria is capable of preventing release
of contaminated platelet components.
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DIAGNOSIS OF CENTRAL VENOUS CATHETER-RELATED THROMBUS BY
TRANSESOPHAGEAL ECHOCARDIOGRAPHY
Gulbas, Z.1, Gunduz, E.1, Akay, M.1 1Eskisehir Osmangazi University,
Eskisehir, Turkey.
Thrombus at the tip of central venous catheters is a problem
frequently seen in patients receiveing intensive chemotherapy.
Because many catheter-related thrombi are asymptomatic, the
true incidence of this complication is difﬁcult to assess and is
likely underestimated. The major complication of the thrombus
is pulmonary embolism. The thrombus incidence observed by
TEE in asymptomatic patients is reported 12.5%. Our aim was
to assess the frequency of central venous catheter-related
thrombus before catheter removal in patients with hematolog-
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